Use of pepsin detection to identify airways reflux in a range of pulmonary diseases

Clin Respir J. 2017 Sep;11(5):666-667. doi: 10.1111/crj.12395. Epub 2015 Oct 12.

Authors

Vicki Strugala¹, Peter W Dettmar¹, Radka Bittenglova², Lucie Fremundova³, Milos Peŝek²

Affiliations

¹ RD Biomed Ltd, Daisy Building (2nd Floor), Castle Hill Hospital, Cottingham, East Yorkshire, UK.
² Department of Pneumology and Phtiseology, Charles University Teaching Hospital, Plzen, Czech Republic.
³ First Department of Internal Medicine, Charles University Teaching Hospital, Plzen, Czech Republic.

PMID: 26404422
DOI: 10.1111/crj.12395

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Biomarkers / metabolism
Czech Republic / epidemiology
Female
Gastroesophageal Reflux / complications
Gastroesophageal Reflux / diagnosis*
Gastroesophageal Reflux / metabolism
Humans
Laryngopharyngeal Reflux / complications
Laryngopharyngeal Reflux / diagnosis*
Laryngopharyngeal Reflux / metabolism
Lung Diseases / complications*
Lung Diseases / diagnosis
Lung Diseases / epidemiology
Male
Middle Aged
Pepsin A / metabolism*
Proton Pump Inhibitors / therapeutic use
Saliva / chemistry*
Young Adult

Substances

Biomarkers
Proton Pump Inhibitors
Pepsin A